Recursion Pharmaceuticals releases updated investor presentation for JP Morgan Healthcare Conference

RECURSION PHARMACEUTICALS, INC.

Investor presentation dated January 13, 2025 attached as Exhibit 99.1
Presentation to be used at JP Morgan Healthcare Conference and in investor meetings
CEO Christopher Gibson signed the 8-K filing on January 13, 2025
Information furnished under Item 7.01 not deemed filed for SEC purposes

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.